Acute Coronary Syndrome Following Long-Term Erlotinib Treatment

Panciu, Traian Constantin; Masgras, Bianca; Ciuca, Catrinel; Ciomag, Raluca; Mihăilescu, Anca; Gurghean, Adriana

Accesso libero

Acute Coronary Syndrome Following Long-Term Erlotinib Treatment

Traian Constantin Panciu

Panciu, Traian Constantin

,

,

,

,

e

20 lug 2018

Volume 15 (2018): Numero 3 (Luglio 2018)

INFORMAZIONI SU QUESTO ARTICOLO

Articolo precedente

Articolo Successivo

Cita

Scarica la copertina

Pubblicato online: 20 lug 2018

Pagine: 61 - 66

DOI: https://doi.org/10.2478/inmed-2018-0023

Parole chiave
Erlotinib, tyrosine kinase inhibitor, non-small cell lung cancer, acute coronary syndrome

© 2018 Traian Constantin Panciu et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Panciu, Traian Constantin

Clinical Hospital Colţea Bucharest

Masgras, Bianca

Clinical Hospital Colţea Bucharest

Ciuca, Catrinel

Clinical Hospital Colţea Bucharest

Ciomag, Raluca

Clinical Hospital Colţea Bucharest

University of Medicine and Pharmacy Carol Davila BucharestRomania

Mihăilescu, Anca

Clinical Hospital Colţea Bucharest

University of Medicine and Pharmacy Carol Davila BucharestRomania

Gurghean, Adriana

Clinical Hospital Colţea Bucharest

University of Medicine and Pharmacy Carol Davila BucharestRomania

Lingua:: Inglese

Frequenza di pubblicazione:: 4 volte all'anno
Argomenti della rivista:: Medicina, Medicina clinica, Medicina interna, Medicina interna, altro, Cardiologia, Gastroenterologia, Pneumologia

Feed RSS della rivista

Acute Coronary Syndrome Following Long-Term Erlotinib Treatment

Traian Constantin Panciu

Bianca Masgras

Catrinel Ciuca

Raluca Ciomag

Anca Mihăilescu

Adriana Gurghean

Pubblicato online: 20 lug 2018

Pagine: 61 - 66

DOI: https://doi.org/10.2478/inmed-2018-0023

Parole chiaveErlotinib, tyrosine kinase inhibitor, non-small cell lung cancer, acute coronary syndrome

© 2018 Traian Constantin Panciu et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Parole chiave
Erlotinib, tyrosine kinase inhibitor, non-small cell lung cancer, acute coronary syndrome